Found "Health Promotion": 980 results
What Can We Learn From Others to Develop a Regional Centre for Infectious Diseases in ASEAN?; Comment on “Operationalising Regional Cooperation for Infectious Disease Control: A Scoping Review of Regional Disease Control Bodies and Networks”
The coronavirus disease 2019 (COVID-19) pandemic has brought the need for regional collaboration on disease prevention and control to the fore. The review by Durrance-Bagale et al offers insights on the enablers, barriers and lessons learned from the experience of various regional initiatives. Trans
What can we learn from India’s COVID-19 Response? Lessons for Thailand and the World
The Delta variant that was first detected in September 2020 in India led to a major outbreak around April 2021. This variant crowded out others due to its higher transmission rate, and it soon became a concern for the rest of the world before the recent surge, on account of the Omicron variant, ecli
Website warned over MMR claims
A website offering parents advice on vaccines has been ordered to remove information about the MMR jab after claiming it could be linked to autism.Babyjabs.co.uk said the three-in-one jab may be causing “up to 10%” of autism in children in the UK.But the Advertising Standards Authority ruled the cla
Webinar on Analysing the Economics of COVID-19: Methodological Challenges and Data Gaps
COVID-19 has dominated headlines for over a year now and that doesn’t look likely to change in 2021. Health economic and epidemiological modelling has played a key and well-publicised role in informing policymaking decisions across the globe in response to the COVID-19 pandemic. These models and pro
We need better value from every rand we spend on healthcare in South Africa
SA IS in the process of preparing for a National Health Insurance (NHI) scheme to reach universal health coverage by 2025. Attaining this goal in a resource-constrained environment will rely in part on understanding which interventions should be prioritised and how resources should be allocated.Our
Watson sues FDA on generic diabetes drug ruling
Watson said that the FDA improperly denied the company’s shared exclusivity on the generic version despite Watson directly following directions received from the regulator.As a result of the FDA’s decision, approval could be delayed for up to six months, Watson said.Watson planned to launch its gene
Watchdog NICE says no to eye drug Lucentis for diabetes
The National Institute for Health and Clinical Excellence (NICE) says ranibizumab, sold under the brand name Lucentis, is too expensive to use in people with diabetic macular oedema.Charities say they will continue to campaign for the drug to be used. At least 50,000 people in the UK are affected by
Washington DC: Improving the Use of Economic Evaluation for Global Health Funders
As part of a series of events coinciding with the launch of the Gates Reference Case, Tommy Wilkinson (Adviser for Health Economics, NICE International) will be speaking on Tuesday 17 June 2014 at a lunch seminar hosted by the Center for Global Development, Washington DC. If you missed our launch ev
Wanrudee Isaranuwatchai, PhD
Dr. Wanrudee Isaranuwatchai is a Secretary General and Senior Researcher of the Health Intervention and Technology Assessment Program Foundation (HITAP), Thailand. She is also an Affiliated Scientist at St. Michael’s Hospital, and an Associate Professor at the Institute of Health Policy, Management and Evaluation, University of Toronto, in Canada.H
W.H.O. Declares Diesel Fumes Cause Lung Cancer
Diesel fumes cause lung cancer, the World Health Organization declared Tuesday, and experts said they were more carcinogenic than secondhand cigarette smoke.The W.H.O. decision, the first to elevate diesel to the “known carcinogen” level, may eventually affect some American workers who are heavily e
10 / Page